MRGHX | VSTSX | MRGHX / VSTSX | |
Total Expense Ratio | 0.89 | 0.01 | 8,900% |
Annual Report Gross Expense Ratio | 0.90 | 0.01 | 9,000% |
Fund Existence | 20 years | 9 years | - |
Gain YTD | 8.037 | 9.284 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.67B | 1.91T | 0% |
Annual Yield % from dividends | 0.44 | 1.20 | 37% |
Returns for 1 year | 6.30 | 16.23 | 39% |
Returns for 3 years | 27.07 | 46.90 | 58% |
Returns for 5 years | 50.89 | 85.95 | 59% |
Returns for 10 years | 97.77 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RCGHX | 15.21 | 0.19 | +1.26% |
Virtus KAR Health Sciences C | |||
VTWAX | 47.23 | N/A | N/A |
Vanguard Total World Stock Index Admiral | |||
FSIUX | 27.80 | -0.13 | -0.47% |
Invesco Dividend Income R5 | |||
GCMTX | 36.18 | -0.22 | -0.60% |
Goldman Sachs Mid Cap Value Inv | |||
ETIMX | 14.74 | -0.10 | -0.67% |
Eventide Balanced Fund Class I |